Clinical trial

Raltegravir Therapy for Women With HIV and Fat Accumulation

NCT00656175

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-09-01

PhasePHASE2

Study timeline

Study start (unknown)2008-09-01Date precision: month

Registry last updated2012-12-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionsunresolved

Lipodystrophyunresolved

Interventions

raltegravirDRUG · verified · RxNorm: raltegravir

Sponsors & collaborators

University of California, Los Angeleslead sponsor

Merck Sharp & Dohme LLCcollaborator

Case Western Reserve Universitycollaborator

Vanderbilt Universitycollaborator

Tufts Universitycollaborator

University Health Network, Torontocollaborator

Mapped research locations

BostonMassachusetts, United States1 Los AngelesCalifornia, United States1 TorontoOntario, Canada1 NashvilleTennessee, United States1 ClevelandOhio, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00656175 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.